Related Experiment Video
Updated: Jun 18, 2026
09:00
An In Vitro Enzymatic Assay to Measure Transcription Inhibition by Gallium(III) and H3 5,10,15-tris(pentafluorophenyl)corroles
Published on: March 18, 2015
Anticancer activity of dinuclear gallium(III) carboxylate complexes
Milena R Kaluderović1, Santiago Gómez-Ruiz, Beatriz Gallego
1Department of Oral, Maxillofacial and Facial Plastic Surgery, University of Leipzig, Nürnberger Str 57, D-04103 Leipzig, Germany.
European Journal of Medicinal Chemistry
|November 21, 2009
Summary
New gallium(III) complexes were synthesized and tested for their cytotoxic activity against various human tumor cell lines. While generally comparable to cisplatin, complex 5 showed promise against head and neck tumors, and complex 3 against ovarian cancer.
Area of Science:
- Organometallic Chemistry: Synthesis and characterization of novel gallium(III) dimeric complexes.
- Medicinal Chemistry: Evaluation of cytotoxic activity of organometallic compounds against human cancer cell lines.
Background:
- Gallium complexes are investigated for their potential therapeutic applications, particularly in oncology.
- Understanding the structure-activity relationship of organometallic compounds is crucial for drug development.
Purpose of the Study:
- To synthesize novel dimeric gallium(III) complexes derived from substituted phenylacetic, furoic, and benzodioxane carboxylic acids.
- To evaluate the in vitro cytotoxic activity of these synthesized gallium(III) complexes against a panel of human cancer cell lines.
- To compare the efficacy of the novel gallium complexes with cisplatin, a standard chemotherapeutic agent.
Main Methods:
- Synthesis of five dimeric gallium(III) complexes using trimethylgallium and corresponding carboxylic acids.
- Structural characterization of complex 5 via X-ray diffraction studies.
- Cytotoxicity assays performed on human tumor cell lines (8505C, A253, A549, A2780, DLD-1) to determine IC(50) values.
Main Results:
- Five dimeric gallium(III) complexes, [Me(2)Ga(micro-O(2)CR)](2), were successfully synthesized.
- Complex 5 exhibited the most potent activity against A253 head and neck tumor cells (IC(50) = 6.6 ± 0.2 μM).
- Complex 3 demonstrated notable activity against A2780 ovarian cancer (IC(50) = 12.0 ± 0.4 μM) and DLD-1 colon carcinoma (IC(50) = 12.4 ± 0.1 μM).
Conclusions:
- The synthesized gallium(III) complexes display cytotoxic effects against human cancer cell lines.
- Complex 5 and Complex 3 show specific promising activity profiles against certain cancer types.
- Further research into these gallium complexes may lead to the development of new anticancer agents.
